Ventyx Biosciences Inc (VTYX)
4.585
-0.12
(-2.65%)
USD |
NASDAQ |
May 07, 16:00
4.585
0.00 (0.00%)
After-Hours: 20:00
Ventyx Biosciences Cash and Short Term Investments (Quarterly): 252.22M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 252.22M |
| September 30, 2023 | 300.82M |
| June 30, 2023 | 332.25M |
| March 31, 2023 | 376.92M |
| December 31, 2022 | 317.94M |
| September 30, 2022 | 412.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 250.45M |
| March 31, 2022 | 254.35M |
| December 31, 2021 | 258.58M |
| September 30, 2021 | 141.95M |
| June 30, 2021 | 102.79M |
| December 31, 2020 | 0.244M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.244M
Minimum
Dec 2020
412.42M
Maximum
Sep 2022
250.08M
Average
256.46M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anavex Life Sciences Corp | 143.76M |
| CERo Therapeutics Holdings Inc | -- |
| Avinger Inc | 5.275M |
| Checkpoint Therapeutics Inc | 4.928M |
| RAPT Therapeutics Inc | 158.86M |